STAT, June 19, 2017. Trump’s team is reportedly considering moves that would do little to address the problem — and would instead please the pharmaceutical industry.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Why Are So Many American Women Having Mastectomies?
Our Bodies Ourselves, June 16, 2017. Breast cancer experts believe that many women undergoing mastectomies do not need them and are getting them out of fear, not because of the actual risks.
Read More »Will a New FDA User Fee Discourage Medical Device Innovation?
Bloomberg BNA, June 12, 2017. De novo is a way to get products to market without going through the FDA’s most stringent review process, premarket approval.
Read More »FDA Questions Effect of Abuse-Deterrent Opioids
Behavioral Healthcare Executive, June 13, 2017. FDA aims to gather information to determine the effects of products with abuse-deterring formulations.
Read More »Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety
Drugwatch, May 8, 2017. “Taxpayers are also paying for agency [funding], but we’re not treated as the customers — the companies are,” Zuckerman said.
Read More »